Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04116437 |
|---|---|
| Brief Title: | Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment |
| First Submitted : | October 1, 2019 |
| First Submitted that Met QC Criteria : | October 2, 2019 |
| First Posted : | October 4, 2019 |
| Last Update Submitted that Met QC Criteria : | April 24, 2024 |
| Last Update Posted : | April 25, 2024 |